CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 49 enrolled
Drug / intervention
Real TMS +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02346708
NCT02346708N/ACompleted
CompareCT.gov

Cortical Physiology as a Therapeutic Target in Parkinson's Disease Related Dementia and Cognitive Dysfunction

University of Colorado, Denver·interventional·Posted Jan 27, 2015·Updated Feb 9, 2021

In Brief

A clinical study evaluating Real TMS and Sham TMS for Parkinson's Disease. Completed, enrolled 49 participants across 1 site.

Detailed Summary

This study plans to learn more about the brain function related to thinking problems in individuals with Parkinson's disease.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsParkinson's Disease
CountriesUnited States
CollaboratorsNational Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke (NINDS)

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedJan 27, 2015
Enrollment StartJan 1, 2014
Primary CompletionDec 1, 2018
Study CompletionDec 1, 2020
TodayJul 2, 2026
Enrollment to primary: 4.9 yearsPosted 11.4 years ago

Interventions

Real TMSdevice

real treatment

Sham TMSdevice

placebo treatment